Compare BridgeBio Pharma Inc (BBIO) vs Godaddy Inc (GDDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Godaddy Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Godaddy Inc trades at $90.75 (market cap $11.49B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | GDDY | |
|---|---|---|
Market Cap | $16.36B | $11.49B |
Sector | Health | Technology |
52-Week High | $90.17 | $148.88 |
52-Week Low | $47.29 | $75.07 |
Enterprise Value | $18.14B | $14.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →
